ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
68 084,17
0,53%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Penwest Pharmaceuticals CO. (MM) (PPCO)

  7. Penwest Pharmaceuticals CO. (MM) (PPCO) Actualités

PPCO

Penwest (PPCO)

Penwest Pharmaceuticals CO. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PPCO
DateHeureSourceTitreSymboleSociété
04/11/201021h23PR Newswire (US)Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
02/11/201011h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
01/11/201012h30PR Newswire (US)Endo Pharmaceuticals Reports Strong Third Quarter 2010 Financial Results; Reaffirms 2010 Financial Guidance and Provides FinanciNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
29/10/201023h16Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
29/10/201023h11Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
25/10/201022h35Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
15/10/201022h45PR Newswire (US)Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and RegistrationNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
14/10/201017h15Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/10/201023h07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/10/201015h35Dow Jones NewsWatson Pharma Gets License To Sell Generic Opana In 2012NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
01/10/201022h57Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
30/09/201023h00PR Newswire (US)Penwest Pharmaceuticals Sets Special Shareholders Meeting Date for Approval of Merger With Subsidiary of Endo PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
27/09/201023h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
27/09/201023h13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
24/09/201012h04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
22/09/201016h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201023h28Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201023h21Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201022h15PR Newswire (US)Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/09/201023h31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/09/201012h06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/08/201018h51Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/08/201018h45Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
14/08/201000h09Business WireFinkelstein Thompson LLP Announces Investigation of Penwest Pharmaceuticals, Co.NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
13/08/201012h06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
12/08/201018h47Business WireLaw Office of Abe Shainberg Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Penwest Pharmaceutic...NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
12/08/201016h26Business WireFaruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Penwest Pharmaceuticals Co. - PPCONASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
11/08/201022h22Business WireThe Law Office of Vincent Wong Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Penwest Pharmaceu...NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
11/08/201002h56Business WireLaw Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Penwest Pharmaceuticals Co.NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
10/08/201019h22Business WireRigrodsky & Long, P.A. Investigates Penwest Pharmaceuticals Co. BuyoutNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
 Showing the most relevant articles for your search:NASDAQ:PPCO

Dernières Valeurs Consultées

BIT
P1O7L7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés